In Depth 14 Apr 2023 mRNA vaccines: a promising future …the forefront in drug delivery systems. Since then, the delivery of mRNA into cells has been extensively studied for the development of vaccines for infectious diseases, but it was not… April 14, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jul 2022 ZyVersa Therapeutics and Larkspur merge to become publicly traded biopharma company …for inflammatory diseases and VAR 200 for renal diseases,” said Daniel J. O’Connor, chairman and CEO of Larkspur. IC 100 and VAR 200 O’Connor said IC 100, an inflammasome ASC… July 21, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 3 Mar 2023 Interview: how has the first gene therapy for hemophilia B transformed research? …vice president and general manager of Commercial Operations Europe at CSL Behring to find out how this therapy has transformed research in hemophilia B, and research in rare diseases at… March 3, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Feb 2024 6 biotech companies making a difference in pediatric care As several diseases tend to affect children at an early age, it is no surprise that there are a number of biotech companies around the world looking to find new… February 29, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2017 British Gene Therapy Gets a Huge £85M Boost in Series B Orchard Therapeutics has raised a big round of financing to gene therapy options for many rare diseases for which there are no treatments. London-based Orchard Therapeutics has managed to raise… December 20, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Expert Advice 16 May 2024 Types of clinical trial designs: The essentials …with rare diseases or when the expected outcome without treatment is poor. These trials can provide preliminary data on the efficacy of a treatment, but they generally offer weaker evidence… May 16, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 19 Feb 2019 How New Microbiome Diagnostic Technologies Can Save Lives …health, while others are responsible for infections and can be instrumental in causing all sorts of diseases, including inflammatory bowel disease or type 2 diabetes. They can even affect medical… February 19, 2019 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jun 2022 Funding doubled for company working on breakthrough auto-immune disease therapeutics …aimed at addressing a range of chronic auto-immune diseases, which affect millions of people worldwide, and particularly type I interferon-mediated diseases such as systemic lupus erythematosus (SLE), dermatomyositis, Sjögren syndrome,… June 30, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 3 Oct 2024 Resolution Therapeutics raises $85 million to advance its macrophage therapy …pipeline growth and manufacturing enhancements, positioning Resolution Therapeutics in a good spot of regenerative medicine for fibrotic diseases. Resolution Therapeutics’ approach: Engineering pro-regenerative macrophages Macrophage therapy is a promising approach… October 3, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 31 May 2022 Therapeutic RNA company receives additional funding …by developing inhalable mRNA therapies for respiratory diseases, and Translate Bio, which develops mRNA therapies for a range of conditions, including respiratory, liver, and infectious diseases. Cover image via Shutterstock… May 31, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 10 Jul 2023 Making an impact through targeting mRNA Biotech company Molecure develops small molecule therapies that can regulate RNA and underexplored protein targets for the treatment of incurable diseases, including cancer and fibrotic and inflammatory diseases. The company,… July 10, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 7 Oct 2019 UK Biotech Launches with €30M Series A to Treat Autoimmune Disease MiroBio has spun out of the University of Oxford with a Series A round of €30M (£27M) to develop treatments for autoimmune diseases that don’t disrupt the immune system as… October 7, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email